September 2001
The Green-back Revolution
Monsanto wants to monopolize basic methods in agricultural biotech. A badly misguided patent office stands ready to help.
By Seth Shulman
Bona fide or not, concerns about the safety of genetically modified crops have been grabbing headlines. But a far bigger story looms in agricultural biotechnology: that of an industry choking on its own patent claims. For a powerful example, consider recent patent activity at Monsanto.
 | Select from the choices above to read the entire article. |
Customer Service
|
Magazine Services
|
Subscribe
|
Other
|
Advertise
|
Massachusetts Institute of Technology